Outcome of adult patients with JIA treated with the biosimilar Benepali(®): results of the biologic register JuMBO

BACKGROUND: To analyze therapy adherence, safety, and outcome in adult patients with juvenile idiopathic arthritis (JIA) treated with the etanercept biosimilar Benepali(®) (Biogen Inc, Cambridge, USA). METHODS: Data from the prospective registry, JuMBO (Juvenile arthritis MTX/Biologics long-term Obs...

Descripción completa

Detalles Bibliográficos
Autores principales: Vollbach, Kristina, Tenbrock, Klaus, Wagner, Nobert, Horneff, Gerd, Klein, Ariane, Foeldvari, Ivan, Haas, Johannes-Peter, Aries, Peer, Gauler, Georg, Striesow, Frank, Hoff, Paula, Scholz, Christine, Tatsis, Stefanie, Seipelt, Eva, Klotsche, Jens, Minden, Kirsten
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9746218/
https://www.ncbi.nlm.nih.gov/pubmed/36514116
http://dx.doi.org/10.1186/s13075-022-02968-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9746218/
https://www.ncbi.nlm.nih.gov/pubmed/36514116
http://dx.doi.org/10.1186/s13075-022-02968-7

Ejemplares similares